INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance

30 окт 2024 07:30:35 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

17 окт 2024 08:00:33 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress

23 сен 2024 08:00:34 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

28 авг 2024 08:00:04 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference

08 авг 2024 08:00:26 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Financial Officer

07 авг 2024 07:40:54 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales Guidance

07 авг 2024 07:30:38 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast

24 июл 2024 08:00:01 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

18 июн 2024 07:30:16 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

10 июн 2024 08:00:34 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference

29 май 2024 08:00:54 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

23 май 2024 08:00:00 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences

08 май 2024 08:00:00 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports First Quarter 2024 Financial Results

07 май 2024 07:30:00 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast

30 апр 2024 08:00:53 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

24 апр 2024 16:01:19 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Prices Public Offering of Common Stock

17 апр 2024 20:46:08 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock

16 апр 2024 16:06:34 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

16 апр 2024 09:45:25 Источник NetDania Notify

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

16 апр 2024 07:00:53 Источник Nasdaq GlobeNewswire